Sign in

CIK 0001446847 · Accelerated filer<br>Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043404176
Phone
617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
  1. 4 Open-market sale SVP, CMO, Head-Res&Drug sold 17,012 shares at $3.66 ($62,264)
  2. 4 Open-market sale Chief Commercial Officer sold 21,526 shares at an average $3.73 ($80,328)
  3. 4 Open-market sale Chief Executive Officer sold 198,283 shares at an average $3.73 ($739,929)
  4. 4 Open-market sale Chief Financial Officer sold 21,944 shares at an average $3.73 ($81,888)
  5. 4 Open-market sale Principal Accounting Officer sold 24,173 shares at an average $3.73 ($90,206)
  6. 4 Planned sale Principal Accounting Officer sold 35,416 shares at $4.60 ($162,914)
  7. 4 Grant or award Director acquired 4,178 shares (grant or award)
  8. 4 Open-market sale Chief Commercial Officer sold 6,016 shares at $3.32 ($19,973)
  9. 4 Grant or award Director acquired 11,718 shares (grant or award)
  10. 4 Open-market sale Chief Commercial Officer sold 1,316 shares at $0.84 ($1,105)
  11. 4 Open-market sale Chief Legal Officer sold 7,754 shares at $0.84 ($6,513)
  12. 4 Open-market sale Chief Financial Officer sold 1,265 shares at $0.84 ($1,063)
  13. 4 Open-market sale Principal Accounting Officer sold 2,846 shares at $0.84 ($2,391)
  14. 4 Grant or award Director acquired 24,193 shares (grant or award)
  15. 4 Grant or award Director acquired 45,000 shares (grant or award)
  16. 4 Grant or award Director acquired 45,000 shares (grant or award)
  17. 4 Grant or award Director acquired 45,000 shares (grant or award)
  18. 4 Grant or award Director acquired 45,000 shares (grant or award)
  19. 4 Grant or award Director acquired 45,000 shares (grant or award)
  20. 4 Grant or award Director acquired 45,000 shares (grant or award)

Page 2 of 41 · 806 filings